Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02926924 · ClinicalTrials.gov registry record · NA

Prophylactic Application of an Incisional Wound Vac to Prevent Wound Complications in Obese Spine Surgery Patients

A NA study, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
68
Enrollment target

NCT02926924: Completed NA study, sponsored by University of Michigan.

NCT02926924 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 68 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02926924, a NA study, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
68 participants
Enrollment target

Study Summary

This is a prospective randomized study evaluating the use of a prophylactic incision wound vac dressing, applied in the OR, on patients undergoing posterior spine surgery with a BMI\>35. Patients are randomized in the operating room to normal postoperative dressing vs. vac dressing. The vac dressing would be left on for 72 hours postoperatively. In the interim, the patients' postoperative care can proceed as usual. Our primary outcomes will be antibiotics or return trip needed to the operating room for wound related complications. The patients only intervention would be the application of an incisional wound vac. The will be no change in the patients postoperative protocol otherwise. This procedure is noninvasive.

Primary Outcome

Count of Patients with Post operative infection requiring return to operating room or prolonged treatment of antibiotics

Interventions

  • DEVICE Wound Vac
  • OTHER Standard Dressing

Trial Details

FieldValue
Enrollment Target 68 participants
Start Date 2011-08-01
Est. Completion 2015-01-15
Phase NA
University of Michigan

1,327 total trials

What the finished NCT02926924 record still lists

NCT02926924 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 68 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 2 interventions - of which Wound Vac is the first listed.

NCT02926924 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02926924 about?

NCT02926924 is a clinical study titled "Prophylactic Application of an Incisional Wound Vac to Prevent Wound Complications in Obese Spine Surgery Patients". This is a prospective randomized study evaluating the use of a prophylactic incision wound vac dressing, applied in the OR, on patients undergoing posterior spine surgery with a BMI\>35. Patients are randomized in the operating room to normal postoperative dressing vs. vac dressing. The vac dressing...

What is the current status of trial NCT02926924?

This trial is currently completed. It is a NA study. The enrollment target is 68 participants. The study started on 2011-08-01. Estimated completion is 2015-01-15.

What interventions are being tested in trial NCT02926924?

The interventions under investigation include: Wound Vac (DEVICE), Standard Dressing (OTHER).

Who is sponsoring clinical trial NCT02926924?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02926924's enrollment target sits among peer trials

68 1133rd of 2000 higher than 862 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02044497 · 68 participants · Phase 4

    Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients

  • NCT03779854 · 68 participants · Phase 2

    Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant

  • NCT03821246 · 68 participants · Phase 2

    Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy

  • NCT04115514 · 68 participants · Phase 2

    Treatment of ARDS With Instilled T3

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02926924, the US trial registry maintained by the National Library of Medicine. NCT02926924 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.